Related Experiment Video

Updated: May 13, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

T-cell modulatory properties of CD5 and its role in antitumor immune responses

Mouna Tabbekh1, M'barka Mokrani-Hammani, Georges Bismuth

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM) U753; Team 1: Tumor Antigens and T-Cell Reactivity; Integrated Research Cancer Institute in Villejuif (IRCIV); Institut de Cancérologie Gustave Roussy (IGR); Villejuif, France.

Oncoimmunology
|March 14, 2013
PubMed

Insights

CD5 is a key regulator of T-cell responses against tumors. Modulating CD5 may enhance T-cell functions, improving cancer immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Cancer Biology
  • T-cell Biology

Background:

  • Immune responses against tumors are regulated by T-cell receptors.
  • CD5 acts as a critical inhibitory molecule in T-cell regulation.
  • Tumor cells can modulate CD5 to evade immune detection.

Purpose of the Study:

  • To review the immunobiology of CD5.
  • To elucidate CD5's role in regulating antitumor CD8 T-cell responses.
  • To explore targeting CD5 for improved cancer immunotherapy.

Main Methods:

  • Literature review of T-cell immunobiology and cancer immunology.
  • Analysis of CD5's regulatory mechanisms in T-cells.
  • Synthesis of current knowledge on CD5 in antitumor immunity.

Main Results:

  • CD5 plays a crucial role in controlling T-cell effector functions.
  • Modulation of CD5 is a strategy employed by tumor-specific cytotoxic T lymphocytes (CTLs).
  • CD5 regulation impacts CTLs' cytotoxic and cytokine secretion capabilities.

Conclusions:

  • CD5 is a significant factor in antitumor immune responses.
  • Targeting CD5 presents a potential strategy to enhance cancer immunotherapy efficacy.
  • Further research into CD5 modulation could lead to novel cancer treatments.
Keywords:
CD5T cellsantitumor immune responsestumor-infiltrating T lymphocytes

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview